166 related articles for article (PubMed ID: 35676731)
1. Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis.
Scheen M; Nowak G; Sanchez B; Teta D
Eur J Med Res; 2022 Jun; 27(1):89. PubMed ID: 35676731
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemic Crisis Due to Parathyroid Adenoma Improved by Continuous Hemodialysis with a Common Calcium Concentration Dialysate: Discussion of Therapeutic Management.
Okuyama H; Sato R; Enomoto K; Asakura J; Hatakeyama T
Intern Med; 2024 Apr; 63(8):1139-1147. PubMed ID: 37690849
[TBL] [Abstract][Full Text] [Related]
3. Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn.
Pradhan M; Leonard MB
Pediatr Nephrol; 2003 May; 18(5):474-6. PubMed ID: 12687453
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
[TBL] [Abstract][Full Text] [Related]
5. [Giant parathyroid adenoma: a rare cause of severe hypercalcemia].
Giunta R; Ferrario S; Zanoli L; Orlando S; Conti A; Benintende D; Castiglione G; Rapisarda F
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281761
[TBL] [Abstract][Full Text] [Related]
6. Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma.
Çalapkulu M; Gul OO; Cander S; Ersoy C; Erturk E; Sagiroglu MF; Saraydaroglu O
J Coll Physicians Surg Pak; 2020 Jul; 30(7):757-759. PubMed ID: 32811610
[TBL] [Abstract][Full Text] [Related]
7. First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma.
Horie I; Ando T; Inokuchi N; Mihara Y; Miura S; Imaizumi M; Usa T; Kinoshita N; Sekine I; Kamihara S; Eguchi K
Endocr J; 2010; 57(4):287-92. PubMed ID: 20051648
[TBL] [Abstract][Full Text] [Related]
8. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
9. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia.
Srámek V; Novák I; Matĕjovic M; Rokyta R; Nalos M; Hora P; Pittrová H
Intensive Care Med; 1998 Mar; 24(3):262-4. PubMed ID: 9565811
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Treatment of medically refractory hypercalcemic crisis.
Au S; Dunham M; Godinez T
Int J Artif Organs; 2012 Jul; 35(7):538-41. PubMed ID: 22476881
[TBL] [Abstract][Full Text] [Related]
12. Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection.
Mezhir JJ; Melis M; Headley RC; Pai RK; Posner MC; Kaplan EL
J Hepatobiliary Pancreat Surg; 2007; 14(4):410-3. PubMed ID: 17653642
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Akinci B; Comlekci A; Tankurt E
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):142-5. PubMed ID: 18561096
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.
Frazao J; Coburn JW
Am J Kidney Dis; 1995 Nov; 26(5):831-5. PubMed ID: 7485141
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
16. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
18. Severe hypercalcaemia from ectopic intact parathyroid hormone secretion treated with continuous renal replacement therapy in a patient with two malignancies.
Hocker N; Story M; Lerud A; Kuppachi S
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187797
[TBL] [Abstract][Full Text] [Related]
19. Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize?
Bro S; Brandi L; Daugaard H; Olgaard K
Perit Dial Int; 1997; 17(6):554-9. PubMed ID: 9655154
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level.
Chagnac A; Ori Y; Weinstein T; Zevin D; Korzets A; Hirsh J; Edelstein S; Gafter U
J Am Soc Nephrol; 1997 Oct; 8(10):1579-86. PubMed ID: 9335387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
